IBEX (IBEX) Stock Price & Analysis
IBEX (IBEX) fell 0.19% to USD 36.83 as of September 9, 2026 at 13:45 UTC, according to Nexqual real-time market data.
IBEX last closed at USD 36.83; the session ranged USD 36.46–36.83 on volume of 1,862 shares. Market capitalization is —, with a 52-week range of USD 25.94–42.99 (NGM). Source: Nexqual, September 9, 2026 at 13:45 UTC.
Key Statistics (as of September 9, 2026 at 13:45 UTC)
| Price | USD 36.83 |
|---|---|
| Change | ▼ 0.19% (down) |
| Previous Close | USD 36.83 |
| Open | USD 36.83 |
| Day Range | USD 36.46 – 36.83 |
| 52-Week Range | USD 25.94 – 42.99 |
| Volume | 1,862 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (IBEX)
Nexqual's technical model rates IBEX "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of September 9, 2026 at 13:45 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 53.84 (neutral) |
| vs SMA50 | Above (USD 35.51) |
| MACD | 0.77 (positive) |
From IBEX's Latest SEC 10-K Filing (filed 2025-09-11)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IMXI | International Money Express, In | USD 14.43 | ▼ 0.59% |
| IIIV | i3 Verticals, Inc. | USD 15.75 | ▼ 5.12% |
| HBT | HBT Financial, Inc. | USD 36.46 | ▼ 0.36% |
| HLIO | Helios Technologies, Inc. | USD 72.15 | ▲ 0.74% |
| INBX | Inhibrx Biosciences, Inc. | USD 124.12 | ▲ 2.43% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 13:45 UTC. This page is informational and not investment advice.